You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First-line care

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Can Digitally Delivered First-line Osteoarthritis Treatment

Recruiting
  • Health Services Accessibility
  • +2 more
  • Digitally delivered first-line treatment for osteoarthritis
  • Face-to-face first-line treatment for osteoarthritis
  • Malmö, Sweden
    Joint Academy
Nov 20, 2023

Healthy Aging, Healthy Lifestyle, Healthy Diet Trial (1. Nutrition; 2. Physical activity; 3. Hypoxic training; 4. Menthal heals

Recruiting
  • Healthy Aging
  • +2 more
  • 1. Nutrition; 2. Physical activity; 3. Hypoxic training; 4. Menthal heals improvement
  • Saint Petersburg, Russian Federation
    First Line Health Care Resort
Oct 28, 2022

Femoroacetabular Impingement Syndrome Trial in Australia, Denmark (Supervised strength exercise intervention, Minimal

Not yet recruiting
  • Femoroacetabular Impingement Syndrome
  • Supervised strength exercise intervention
  • Minimal educational intervention (usual care)
  • Melbourne, Australia
  • +4 more
Jun 27, 2023

NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Nov 7, 2023

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Advanced Colorectal Carcinoma Trial in Beijing (palliative care group first-line scheme+compound kushen injection, palliative

Recruiting
  • Advanced Colorectal Carcinoma
  • palliative care group first-line scheme+compound kushen injection
  • palliative care group first-line scheme
  • Beijing, China
    Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Jun 7, 2023

Birth, First, Care Pattern, Maternal, Care Trial in Tunceli (Midwifery care applied in line with Midwife-Pregnant cooperation)

Recruiting
  • Birth, First
  • +3 more
  • Midwifery care applied in line with Midwife-Pregnant cooperation
  • Tunceli, Turkey
    Munzur University
Jul 12, 2023

Gynecologic Cancer Trial (Experimental product - Fortifit® Powder, Standard of care)

Not yet recruiting
  • Gynecologic Cancer
  • Experimental product - Fortifit® Powder
  • Standard of care
  • (no location specified)
Oct 14, 2023

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Peripheral T Cell Lymphoma Trial in Duarte, Aurora, Philadelphia (Nivolumab and EPOCH)

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Nivolumab and EPOCH
  • Duarte, California
  • +2 more
Jan 6, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 1, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 7, 2023

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

Carcinoma, Hepatocellular Trial in India (Lenvatinib)

Recruiting
  • Carcinoma, Hepatocellular
  • Bangalore, Karnataka, India
  • +10 more
Feb 1, 2023

Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

Recruiting
  • Epithelial Ovarian Carcinoma Stage III
  • +5 more
  • nab-paclitaxel combined with carboplatin
  • Guangzhou, Guangdong, China
  • +10 more
Feb 19, 2023

Metastatic Castrate Resistant Prostate Cancer, BRCA1, BRCA2, PALB2 Genetic Mutations Trial in United States (Carboplatin,

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • +2 more
  • West Los Angeles, California
  • +13 more
Nov 23, 2022

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023

Ovarian Tumors, Ovarian Epithelial Cancer Trial in Czechia, Poland (DCVAC/OvCa with Standard of Care, DCVAC/OvCa sequentially

Completed
  • Ovarian Neoplasms
  • Ovarian Epithelial Cancer
  • DCVAC/OvCa with Standard of Care
  • +2 more
  • Brno, Czechia
  • +12 more
May 3, 2022

Metastatic Colorectal Cancer Trial in Marseille (Oncogramme results available, Oncogramme results unavailable)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Oncogramme results available
  • Oncogramme results unavailable
  • Marseille, France
    Hôpital Saint Joseph Marseille
Mar 18, 2022

Metastatic or Locally Advanced NSCLC Trial in Ramat Gan (Durvalumab, Tremelimumab, Low dose irradiation)

Recruiting
  • Metastatic or Locally Advanced NSCLC
  • Ramat Gan, Israel
    Sheba Medical Centre
Jan 9, 2022

Helicobacter Pylori Infection Trial in China (Amoxicillin, Tetracycline tid, Tetracycline qid)

Not yet recruiting
  • Helicobacter Pylori Infection
  • Zhengzhou, Henan, China
  • +5 more
Jun 28, 2022

Nintedanib in Indian Non-small Cell Lung Cancer After First-line

Completed
  • Non-small Cell Lung Cancer
    • Anand, India
    • +10 more
    Oct 12, 2022